NTRK1 and Miyoshi myopathy: In some canine MM melanomas, pathway activation may be due loss of PTEN [31,50], mutations in NRAS occur in a few cases (similar to human MM) [31,45,57], or over-expression of receptor tyrosine kinases, such as platelet derived growth factor receptor (PDGFR) could be possible [56].